UK Research and Innovation (UKRI): Early Ideas to Improve the Delivery of Nucleic Acid Therapeutics (expression of interest)

The NATA programme supports multidisciplinary approaches to the development of NATs. The promise of NATs has been demonstrated in the clinic. However, their development and widespread use has been hindered by a lack of robust techniques to achieve targeted delivery to specific tissues, improve stability and facilitate uptake into cells, without compromising on safety or effectiveness.

This funding opportunity will support a consortium to tackle major barriers to safe and effective NAT delivery.

Funding: £6,000,000 for 3 years. The principal investigator must be UK based.

https://www.ukri.org/opportunity/early-ideas-to-improve-the-delivery-of-nucleic-acid-therapeutics/